Experience with a new implantable pacer-, cardioverter-defibrillator for the therapy of recurrent sustained ventricular tachyarrhythmias: a step toward a universal ventricular tachyarrhythmia control device.

Détails

ID Serval
serval:BIB_8C1FCB0BAFA5
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Experience with a new implantable pacer-, cardioverter-defibrillator for the therapy of recurrent sustained ventricular tachyarrhythmias: a step toward a universal ventricular tachyarrhythmia control device.
Périodique
Pacing and Clinical Electrophysiology : Pace
Auteur(s)
Fromer M., Schläpfer J., Fischer A., Kappenberger L.
ISSN
0147-8389[print], 0147-8389[linking]
Statut éditorial
Publié
Date de publication
08/1991
Volume
14
Numéro
8
Pages
1288-1298
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
Ten consecutive patients (mean age 57.9 +/- 7.6 years) were treated with an investigational tachyarrhythmia control device, the implantable Medtronic Pacer-, Cardioverter-, Defibrillator model 7216A or 7217B. All patients had coronary artery disease with old myocardial infarctions and presented hemodynamically significant sustained ventricular tachyarrhythmias not suppressed by antiarrhythmic drug therapy and unrelated to acute myocardial infarction. In two patients a nonthoracotomy lead system was implanted. Lowest effective defibrillation energy ranged from 5 to 18 joules (mean 12.2 +/- 4 joules) for the epicardial bielectrode systems and were 15 and 18 joules for the nonthoracotomy lead system implants. The postoperative periods were unremarkable. Follow-up ranged from 7 to 19 months (mean 13.8 +/- 4.5 months). Spontaneous tachyarrhythmia episodes were detected and treated by the device in six patients, five of them received staged therapies. No deaths occurred and no hospital admissions were necessary for device related or ventricular tachyarrhythmia related complications. In conclusion, this integrated device represents a major step toward the development of a universal ventricular arrhythmia control device.
Mots-clé
Aged, Cardiac Pacing, Artificial, Electric Countershock, Electrocardiography, Heart Ventricles, Humans, Male, Middle Aged, Pacemaker, Artificial, Prostheses and Implants, Tachycardia/physiopathology, Tachycardia/therapy, Ventricular Fibrillation/physiopathology, Ventricular Fibrillation/therapy
Pubmed
Web of science
Création de la notice
15/02/2008 11:30
Dernière modification de la notice
20/08/2019 14:50
Données d'usage